Results 241 to 250 of about 20,415 (303)

Exploring claudin proteins: from sequence motifs to their impact on tight junction-mediated signaling pathways. [PDF]

Amino Acids
Bao L, Yang S, Zhao W, Zuo Y.
europepmc   +1 more source

EHD4 and ASAP2 are critical negative regulators of the claudin‐5‐based endothelial barrier

The FEBS Journal, Volume 293, Issue 7, Page 2067-2085, April 2026.
Cell‐surface CLDN‐5 protein levels can be evaluated using a probe that can bind to the extracellular domains of CLDN‐5. A probe derived from Clostridium perfringens enterotoxin allows us to isolate cells with high CLDN‐5 protein levels from a knockout cell library.
Yosuke Hashimoto, Gergő Porkoláb, Natalie Hudson, Jeffrey O'Callaghan, Nicole Hanley, Conor Delaney, Mária A. Deli, Peter Westenskow, Matthew Campbell   +8 more
wiley   +1 more source

The claudin-like molecule CLC-3 regulates neuromuscular function in Caenorhabditis elegans by modulating cholinergic signalling

Ahuja A, Rastogi A, Liu H, Sahu A, Kumar H, Jayaraj J, Hu Z, Babu K.   +7 more
europepmc   +1 more source

Research progress on the role of Claudin family proteins in mediating blood-brain barrier selective permeability in tumor metastasis. [PDF]

Am J Transl Res
Wei D, Xu M, Cui W, Feng X, Wei L, Wang K, Li S, Gao S.   +7 more
europepmc   +1 more source

Claudin‐18 expression in gastric type adenocarcinoma and HPV‐associated adenocarcinoma of the uterine cervix

Histopathology, Volume 88, Issue 5, Page 1003-1015, April 2026.
CLDN18 (43‐14A) is expressed in most gastric type adenocarcinomas and a much smaller proportion of HPV‐associated adenocarcinomas. Expression of CLDN18.2 mRNA but not CLDN18.1 mRNA is confirmed in both gastric type adenocarcinomas and HPV‐associated adenocarcinomas.
Nobuko Yasutake, Yuki Yokawa, Takehiro Tanaka, Riri Mishima, Misato Komamizu, Ryosuke Kuga, Rina Jiromaru, Shinichiro Kawatoko, Kenzo Sonoda, Hideaki Yahata, Kiyoko Kato, Yoshinao Oda, Hidetaka Yamamoto   +12 more
wiley   +1 more source

Essential amino acids preserve intestinal barrier integrity <i>via</i> mitochondrial protection in obesity and gut inflammation. [PDF]

Front Pharmacol
Spataro L, Ragni M, Segala A, Vetturi A, Marcotto GS, Canciani L, Carruba MO, Aquilani R, Collo G, Valerio A, Nisoli E, Ruocco C.   +11 more
europepmc   +1 more source

Transforming Treatment: The Impact of Bariatric Surgery on Oral Drug Absorption

Obesity Reviews, Volume 27, Issue 4, April 2026.
ABSTRACT Obesity represents a significant threat to global public health, with an estimated 16% of adults worldwide (2022) being classified as people with obesity, with a body mass index of 30 or more. Bariatric surgery is regarded as the most effective treatment option for people with obesity, with the three main types of bariatric surgery being ...
Danielle Wigg, Andrea Edginton, Matthew D. Jones, Nikoletta Fotaki   +3 more
wiley   +1 more source

Microbiota-Derived Regulation of AhR and VDR Signaling in Intestinal Inflammation: Protective Roles of Prebiotics, Probiotics, and Postbiotics. [PDF]

Int J Mol Sci
Huang FC.
europepmc   +1 more source

Immunomodulatory effects of cathelicidin in the gut–brain axis: A novel link between mucosal immunity and neuroinflammation

Experimental Physiology, Volume 111, Issue 4, Page 1733-1745, 1 April 2026.
Abstract Cathelicidins are evolutionarily conserved host defence peptides known for their dual antimicrobial and immunomodulatory functions. Among them, LL‐37 in humans and CRAMP in rodents have emerged as crucial regulators of both mucosal immunity and CNS inflammation.
Mehrdad Nourizadeh, Amir Arsalan Ghahari, Ehsan Zandi, Seyedeh Zeynab Rasouli, Shaghayegh Davari, Mobina Hoseinzadeh, Mir Alireza Nourazar   +6 more
wiley   +1 more source

Whispering Through the Barrier: Signaling Interfaces for Peripheral Regulation of Brain Function in Obesity. [PDF]

J Neurochem
Kaya MZ, Stranahan AM.
europepmc   +1 more source